Physician

David Alan Lewis, MD

According to 2025 Medicare claims, David Lewis, MD (NPI: 1760522817) practices ophthalmology in the Walla Walla, WA market, with the plurality of this provider's patient population coming from Walla Walla, WA. This provider's primary affiliated billing organization is ANDREW S EDWARDS MD PC (NPI: 1083076624; TIN: 811771947) and primary practice location at 99362-4363.

Lewis' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 997 traditional Medicare patients, billed 26,944 HCPCS/CPT codes, and received $1,541,974 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 921 prescription claims across 244 beneficiaries totaling $45,416 in drug costs, led by Rhopressa (Netarsudil Mesylate). 2021 DME data shows 13 claims. Open Payments data shows 11 records totaling $319. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $108,078 to $1,541,974. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $81,077 and ending at $45,416. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	370	1,029	$108,078
2016	452	1,419	$122,080
2017	767	4,817	$444,074
2018	921	6,935	$808,892
2019	903	6,934	$1,007,039
2020	948	7,355	$1,201,565
2021	1,070	8,870	$1,445,353
2022	1,038	9,266	$1,440,151
2023	1,033	17,640	$1,427,340
2024	997	26,944	$1,541,974

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	205	899	$81,077
2016	141	723	$63,178
2017	171	629	$53,222
2018	170	735	$71,047
2019	159	707	$76,022
2020	172	793	$79,775
2021	190	801	$78,842
2022	187	818	$71,132
2023	175	715	$65,439
2024	244	921	$45,416

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	13	13	$1,291
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	438	600	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	400	458	$83
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	248	406	$64
92134	Imaging of retina	615	1,479	$29
92250	Photography of the retina	257	271	$24

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rhopressa	Netarsudil Mesylate	11	753	$8,198
Latanoprost	Latanoprost	257	15,673	$2,861
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	147	8,120	$2,694
Ketorolac Tromethamine	Ketorolac Tromethamine	109	4,578	$2,506
Prednisolone Acetate	Prednisolone Acetate	42	2,606	$1,938

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	11	$319	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David Alan Lewis, MD?

Tedicare shows public-source Medicare data for David Alan Lewis, MD (NPI 1760522817), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Alan Lewis, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Alan Lewis, MD?

David Alan Lewis, MD is linked to ANDREW S EDWARDS MD PC (billing NPI 1083076624) in the available physician profile data.

Does David Alan Lewis, MD have Open Payments data?

David Alan Lewis, MD has 11 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.